Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases
Lung Disease Clinical Trials
A listing of Lung Disease medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Last
Alabama
GSK Investigational Site
Andalusia Alabama 36420Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Pearl Investigative Site
Andalusia Alabama
Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease
Pearl Investigative Site
Anniston Alabama
Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease
Pearl Investigative Site
Athens Alabama
Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease
The University of Alabama at Birmingham
Birmingham Alabama 35249Updated
A clinical research study of Treatment plus Optimal Medical Therapy and Optimal Medical Therapy for the treatment of Pulmonary Emphysema
View More »
UAB Lung Health Center
Birmingham Alabama 35294
A clinical trial to evaluate treatments using tetomilast and placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Birmingham Alabama 35205
A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)
GSK Investigational Site
Birmingham Alabama 35294
A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Birmingham Alabama 35209Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Birmingham Alabama 35233Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham
Birmingham Alabama 35233
Patients are needed to participate in a clinical research study of Liposomal amikacin for inhalation and placebo to evaluate Pulmonary Nontuberculous Mycobacterial Lung Disease
205.477.001039 Boehringer Ingelheim Investigational Site
Birmingham Alabama Updated
Patients are needed to participate in a clinical research study of tiotropium bromide and Placebo to evaluate Pulmonary Disease, Chronic Obstructive
205.477.001050 Boehringer Ingelheim Investigational Site
Birmingham Alabama Updated
Patients are needed to participate in a clinical research study of tiotropium bromide and Placebo to evaluate Pulmonary Disease, Chronic Obstructive
Pearl Investigative Site
Birmingham Alabama
Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease
GSK Investigational Site
Birmingham, Alabama 35242Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Pearl Investigative Site
Florence Alabama
Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
Novartis Investigative Site
Gulf Shores Alabama 36547
A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
Novartis Investigative Site
Huntsville Alabama 35801
A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)
GSK Investigational Site
Huntsville Alabama 35801Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Jasper Summit Research LLC
Jasper Alabama 35501
A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease
Pearl Investigative Site
Jasper Alabama
Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
GSK Investigational Site
Jasper Alabama 35501
Patients are needed to participate in a clinical research study evaluating Umeclidinium/vilanterol, Fluticasone propionate/salmeterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Novartis Investigative Site
Mobile Alabama 36608
A clinical research study of NVA237, Long-acting beta 2-agonist (LABA) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
GSK Investigational Site
Mobile Alabama 36608Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Pearl Investigative Site
Mobile Alabama
Patients are needed to participate in a clinical research study evaluating GFF MDI (PT003), GP MDI (PT001), FF MDI (PT005) and Placebo for the treatment of Chronic Obstructive Pulmonary Disease (COPD)
GSK Investigational Site
Mobile Alabama 36608
Patients are needed to participate in a clinical research study of Umeclidinium bromide 62.5mcg, Umeclidinium bromide 125mcg and Fluticasone propionate 250mcg/Salmeterol 50mcg to evaluate Pulmonary Disease, Chronic Obstructive
Novartis Investigative Site
Montgomery Alabama 36109
A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)
205.478.00243 Boehringer Ingelheim Investigational Site
Montgomery Alabama Updated
A Phase 4 clinical study for patients with Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Montgomery Alabama 36109Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Montgomery/Alabama Alabama 36106Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Ozark Alabama 36360Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Pell City Alabama 35128Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Pisgah Alabama 35765Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Tuscumbia Alabama 35674Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Novartis Investigative Site
Vestavia Alabama 35216
Patients are needed to participate in a clinical research study of QVA149, Long acting b2-agonist and Placebo to evaluate Chronic Obstructive Pulmonary Disease (COPD)
Arizona
Novartis Investigative Site
Additional Locations Arizona
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Additional Locations Arizona
A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)
Novartis Investigative Site
Chandler Arizona 85224
A clinical trial to evaluate treatments using NVA237 and Placebo for patients with Chronic Obstructive Pulmonary Disease
Clinical Trial Connection
Flagstaff Arizona 86001
A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease
205.478.00208 Boehringer Ingelheim Investigational Site
Flagstaff Arizona Updated
A Phase 4 clinical study for patients with Pulmonary Disease, Chronic Obstructive
View More »
GSK Investigational Site
Flagstaff Arizona 86001Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
205.478.00260 Boehringer Ingelheim Investigational Site
Glendale Arizona Updated
A Phase 4 clinical study for patients with Pulmonary Disease, Chronic Obstructive
GSK Investigational Site
Glendale Arizona 85306Updated
Patients are needed to participate in a clinical research study evaluating fluticasone furoate/vilanterol, fluticasone furoate, vilanterol and Placebo for the treatment of Pulmonary Disease, Chronic Obstructive
Novartis Investigative Site
Mesa Arizona 85205
A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)
Pearl Investigative Site
Mesa Arizona
Patients are needed to participate in a clinical research study to evaluate Chronic Obstructive Pulmonary Disease
Pulmonary Associates P.A.
Phoenix Arizona 85006
A clinical research study of Inhaled nitric oxide and Placebo for the treatment of Pulmonary Hypertension or Chronic Obstructive Pulmonary Disease
Pulmonary Associates
Phoenix Arizona 85006Updated
A clinical research study of Treatment plus Optimal Medical Therapy and Optimal Medical Therapy for the treatment of Pulmonary Emphysema
Phoenix Arizona
A Phase 2 clinical study for patients with Chronic Obstructive Pulmonary Disease
Novartis Investigative Site
Phoenix Arizona 85018
A Phase 3 clinical study for patients with Chronic Obstructive Pulmonary Disease (COPD)
GSK Investigational Site
Phoenix Arizona 85006
A Phase 3 clinical study for patients with Pulmonary Disease, Chronic Obstructive
First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Last